R66-31-5. Potency Testing and Standards

(1) A batch of cannabinoid product shall have the following determined and listed on the COA: (a) quantity of any cannabinoid it is known to contain, including any THC analog; and (b) the cannabinoid profile by percentage of mass. (2) Cannabinoid products may not exceed the cannabinoid product THC level. (3) A lot or batch of cannabis plant product, cannabis concentrate, or cannabis product fails quality assurance testing for cannabinoid content if: (a) any of the artificially derived cannabinoids listed in Table 1 are found to be present; or (b) greater than 10% of the total cannabinoid peak area is comprised of unknown cannabinoids after peaks smaller than 1% of the total peak area have been excluded as determined by high-performance liquid chromatography with a diode array detector (HPLC-DAD); or (c) a newly identified cannabinoid approved by the department is present in a quantity greater than 2% by mass. (4)(a) The department recognizes the following as newly identified cannabinoids: (b) Cannabicitran (CBTC), CAS 31508-71-1. TABLE 1 Artificially Derived Cannabinoids Analyte Chemical Abstract Service (CAS) Registry number Hexahydrocannabinol (HHC) 36403-90-4, 36403-91-5 3-Heptyl-delta(1)-tetrahydrocannabinol (THCP) 54763-99-4, 51768-60-6 tetrahydrocannabinol acetate (THC-OAc) 23132-17-4, 23050-54-6